Date:   3/16/2017 8:50:14 AM ( 8 y ago)
Hits:   561
URL:   https://www.curezone.org/forums/fm.asp?i=2358744

In the following patent from 2014 from the University of Massachussets, it is demonstrated that cataract can be reversed by eyedrops containing agents that directly interfere with the electrostatic attraction between beta- and gamma- crystallins:
http://www.google.com/patents/WO2014152818A1?cl=en
Some of the agents mentioned in this patent had already been discovered in a patent from MIT in 1986, but were of course ignored by the eye profession. It is also explained that alpha-crystallin exerts its chaperone effect by disrupting the electrostatic attraction between beta- and gamma crystallins. The new sterol anticataract eyedrops soon to be clinically trialled aim to revive alpha-crystallin, therefore, by working through alpha-crystallin, they reverse the cataract on the beta- and gamma- crystallins indirectly.
 

<< Return to the standard message view

fetched in 0.03 sec, referred by http://www.curezone.org/forums/fmp.asp?i=2358744